MEI Pharma, Inc. (MEIP)

[Doktornolittle]

Results posted on MEIP website: Median OS not reached yet but 14.3 months so far. They will be doing a Phase 3 for AML.

"These are impressive results by virtually any measure for a group of patients in dire need of effective new treatment options," said Dr. Garcia-Manero. "Not only did we observe a high rate of responses, but many occurred rapidly and continued to improve with ongoing therapy. Most importantly, we are seeing an encouraging trend in overall survival, particularly among patients who achieved a complete response. These data clearly support further development of Pracinostat in combination with azacitidine for the treatment of elderly patients with AML."

http://investor.meipharma.com/2015-12-07-MEI-Pharma-Announces-Positive-Results-from-Phase-II-Study-of-Pracinostat-in-Acute-Myeloid-Leukemia-Plans-to-Initiate-Phase-III-Registration-Study